Ben Click

‼️Important HBV reaction prevention in IBD pts. Note JAKi mod risk > aTNF in sAg(-), cAb(+) -> antiviral ppx. @GI_PharmD @JHashashMD @fudmanMD @Waseem_AhmedMD @IBDPharmD
gastrojournal.org/article/S0016-…

Crowdsourcing IBD journal club ideas. What are your biggest clinical impact recent articles? @fudmanMD @DCharabaty @IBDimmunology @Waseem_AhmedMD @EdwardLoftus2 @MLongMD @Bealoquebea

Makes sense and highlights 💊💉needs after ASUC 🏥, but still high (~50%) rate of “treatment failure” in IVCS responsive -> IFX + AZA. ? rapid steroid taper in IFX. ? No proactive TDM in high risk pop. Other thoughts? @Waseem_AhmedMD @berinsj @IBDimmunology

First non aTNF to demonstrate efficacy in RCT to 🛑 endo recurrence. Good option and reassuring data to have.

Ever wonder if you should biopsy normal neoTI after resection in CD?

▶️Normal (i0) endoscopy
▶️Active inflammation
⬆️POR risk

More evidence that active 🔬 disease can risk stratify IBD clinical risk. @RavShahMD @IBDBen @DrJordanAxelrad @EdBarnesMD

journals.lww.com/ajg/abstract/9…